Dr. Nandini Verma
Chemotherapy is given to patients suffering from different types of cancer but even after treatment, these drugs can cause residual disease giving rise to persister phenotype and are much prone to metastasis. Inhibition of chemoresistance is very much important to prevent relapse. I am in this lab to solve this pathway which is very much tangled and need to be sorted for target therapeutics. For that I am currently working on the project to understand the role of oxidative stress managing pathways in TNBC subtypes and it's correlation with metastasis.